Solid Biosciences Inc. (SLDB) SEC Filings — 2025
7 SEC filings for Solid Biosciences Inc. (SLDB) in 2025.
Filings
- Solid Biosciences' R&D Surge Drives 52% Net Loss Increase — 10-Q · Nov 3, 2025
- Solid Biosciences' Q2 Loss Widens to $25.2M Amid R&D Shifts — 10-Q · Aug 12, 2025
- Solid Biosciences Files 8-K: Director Changes & Shareholder Votes — 8-K · Jun 13, 2025
- Solid Biosciences Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Solid Biosciences DEF 14A: Executive Compensation Details — DEF 14A · Apr 25, 2025
- Solid Biosciences Files 2024 10-K, Details Gene Therapy Progress — 10-K · Mar 6, 2025
- Solid Biosciences Inc. 8-K Filing — 8-K · Feb 18, 2025